Evidence map›Paper›PMID 42637746›Full record

ArticleNature communications2026

Distinct Filament Conformation for Receptor-Bound Amyloid-β from Alzheimer's Disease Brain.

Mikhail A Kostylev, Carmen Butan, Graham P Roseman, Yangyi Liu, Tanina Arab, Ruibing Wu, Pallavi Gopal, Stephen M Strittmatter

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Mikhail A Kostylev *Departments of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Carmen Butan *Departments of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Graham P Roseman *Departments of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Yangyi LiuDepartments of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Tanina ArabDepartments of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Ruibing WuDepartments of Neuroscience, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0009-0009-5985-7168
Pallavi GopalDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-4708-8479
Stephen M StrittmatterDepartments of Neuroscience, Yale School of Medicine, New Haven, CT, USA. stephen.strittmatter@yale.edu.ORCID http://orcid.org/0000-0001-8188-3092

Funding

Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2020 to 2026
$30.2M
Prion Protein in Alzheimer's Disease PathophysiologyR01AG034924 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2010 to 2026
$9.6M
Yale Clinical and Epidemiology Research in Neurology (CERN) Training ProgramT32NS105583 · NINDS · YALE UNIVERSITY · PI LICHTMAN, JUDITH H, SPUDICH, SERENA S · 2019 to 2023
$1.1M
NIA NIH HHS P30 AG066508NIA NIH HHS R01 AG034924NINDS NIH HHS T32 NS105583U.S. Department of Health & Human Services | National Institutes of Health (NIH) P30AG066508U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AG034924U.S. Department of Health & Human Services | National Institutes of Health (NIH) T32NS105583
6 · The paper itself

Abstract

Alzheimer's disease is triggered by amyloid-β, with symptoms linked to synapse loss. Oligomeric amyloid-β, rather than monomeric or fibrillar amyloid-β, has been proposed to be the proximate mechanistic cause, but the relevant molecular characteristics have remained unclear. To define the biologically relevant species, we isolated a receptor-bound amyloid-β pool from Alzheimer's disease brain by release with a receptor antagonist and purification to homogeneity. This discrete receptor-bound amyloid-β pool is ten times more abundant than free unbound amyloid-β and is comprised of 65 nm long filaments. The tips of these short filaments bind to prion protein and drive synapse loss from human neurons. Cryo-electron microscopy shows that the receptor-bound amyloid-β consists of two symmetric S-shaped amyloid-β monomers per filament rung. The overall structure is similar to much longer plaque-associated amyloid-β filaments from the same brain and fails to reveal an unrelated "oligomeric" conformation. Nonetheless, the receptor-bound amyloid-β can be distinguished from plaque filaments by the tilt angle of repeating amyloid-β subunits within each filament rung, by amino terminal conformation, by length and by amyloid seeding properties. Characterizing receptor-bound amyloid-β provides insight into neuronal dysfunction separate from plaque aggregation.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesBrainAnimalsCryoelectron MicroscopyHumansNeuronsPlaque, AmyloidPrionsProtein BindingProtein ConformationSynapsesAmyloid beta-PeptidesPrions

Identifiers

PMID42637746
PMCPMC13503723

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.